Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
HIV-1 has claimed the lives of millions of people globally and continues to spread despite development of highly active antiretroviral therapy. In 2013, 2.1 million new infections occurred and over 35 million people were living with HIV-1 infection. A prophylactic HIV-1 vaccine that can prevent infection or reduce viremia and subsequent transmission will always be an important part of the solution to bring this epidemic under control.
In this thesis, the first HIV-1 vaccine candidat...Expand abstract
- Publication date:
- Type of award:
- Level of award:
- Awarding institution:
- University of Oxford
- Copyright holder:
- Tina Ahmed
- Copyright date:
For original published NPG article detailing results from chapters 3 and 5 refer to URL: http://www.nature.com/mt/journal/v22/n2/full/mt2013248a.html.
Molecular Therapy (2014); 22 2, 464–475. doi:10.1038/mt.2013.248
If you are the owner of this record, you can report an update to it here: Report update to this record